KROS NASDAQ · Healthcare · FY 2025-12-31

Keros Therapeutics, Inc.

0.04.28.412.616.8ABVfair 15.51buy ≤ 11.63EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 10.07 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USD
Verdict
Buy
Buy zone
Asset Floor Buy
Archetype
No-Moat
Confidence
●○○ Low · 1/4

Price
10.070 USD
Market cap
196.8M USD
P / B
0.65
P / E
4.38
EPS
2.300
DPS / yield
(0.0%)
NAV / share
15.510
Graham number
28.331
Z'' score
11.55
Piotroski F
6 / 9
Beneish M
ROIC vs WACC
196.3% vs 10.4%

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.